MedPath

Whether Opioids Are Factor That Induced POD?

Not Applicable
Completed
Conditions
Postoperative Delirium
Interventions
Registration Number
NCT05596071
Lead Sponsor
Zhejiang Cancer Hospital
Brief Summary

The purpose of this study was to investigate whether perioperative use of low doses of opioids could reduce postoperative delirium .

Detailed Description

Postoperative delirium (POD) is a common postoperative complication of the elderly caused by a variety of factors. POD is an acute neuropsychiatric disorder characterized by disturbance of attention consciousness and cognitive function fluctuation, and more than 40% of elderly patients have symptoms of hypoactivity POD.The incidence of POD is as high as 17% to 61% in patients with neurocognitive impairment and patients undergoing complex or emergency surgery, which usually occurs between 1 and 3 days after surgery. POD will lead to prolonged hospital stay, functional impairment and even death. How to prevent and treat POD is an urgent clinical problem to be solved at present.

Opiates are commonly used perioperative sedatives and analgesics, which may be associated with the occurrence of postoperative POD in elderly patients and increase the risk of POD. It is not clear whether perioperative use of low doses of opioids could reduces the incidence of POD in elderly patients. In this study, reducing-opioids anesthesia was defined as the use of 1/3 of the conventional opioid dose to observe whether reducing-opioids anesthesia affected the incidence of POD in elderly patients undergoing gastric cancer surgery

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
130
Inclusion Criteria
  • Patients' age ≥65 years
  • Underwent elective radical gastrectomy
Exclusion Criteria
  • Mini-Mental Scale Test (MMSE) Exclusion criteria: illiteracy <18, primary school <21, junior school and above <25
  • Preoperative clear systems and spiritual history of neurological disease or long-term use of sedatives or antidepressants
  • History of alcohol abuse or a history of drug dependence
  • Have brain surgery or trauma
  • Cannot with the completion of tests of Postoperative Cognitive Dysfunction
  • Refused to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sufentanyl+Epidural analgesiaEpidural catheterCombined use of sufentanil and ropivacaine for intraoperative and postoperative analgesia
Epidural analgesiaEpidural catheterOnly use of ropivacaine for intraoperative and postoperative analgesia
Sufentanyl+Epidural analgesiaSufentanil CitrateCombined use of sufentanil and ropivacaine for intraoperative and postoperative analgesia
Sufentanyl+Epidural analgesiaRopivacaine 0.75% Injectable SolutionCombined use of sufentanil and ropivacaine for intraoperative and postoperative analgesia
Epidural analgesiaRopivacaine 0.75% Injectable SolutionOnly use of ropivacaine for intraoperative and postoperative analgesia
Primary Outcome Measures
NameTimeMethod
Incidence of postoperative delirium3 days after surgery

Richmond agitation and sedation scale(RASS), the RASS score was divided into 10 sedation scales, ranging from +4 to -5, representing the patient's degree from "aggressive" to "unconscious," with each score corresponding to a state of consciousness. When the RASS score was ≥-3, the CAM-ICU assessment was performed.

Secondary Outcome Measures
NameTimeMethod
Anaesthesia related adverse event3 days after surgery

Nausea and vomiting

Visual analogue scale(VAS)3 days after surgery

VAS is a scale of 11 numbers ranging from 0 to 10, with 0 representing no pain and 10 representing the most pain. Patients choose one of the 11 numbers to represent the pain level according to their own pain.

0: no pain;

Less than 3 points: mild pain, tolerable;

4-6 points: the patient's pain and affect sleep, still tolerable;

7-10: Patients have increasing pain, pain is unbearable, affect appetite, affect sleep.

blood pressure3 days after surgery

Hypertension or hypotension was defined as an increase or decrease in mean arterial pressure of more than 30% at baseline

Trial Locations

Locations (1)

Zhejiang Cancer Hospital

🇨🇳

Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath